Literature DB >> 25001309

In vitro activities of eight antifungal drugs against 104 environmental and clinical isolates of Aureobasidium pullulans.

M Javad Najafzadeh1, Deanna A Sutton2, M Saradeghi Keisari1, H Zarrinfar1, G Sybren de Hoog3, Anuradha Chowdhary4, Jacques F Meis5.   

Abstract

Aureobasidium pullulans is an unusual agent of phaeohyphomycosis. The in vitro activities of antifungals against 104 isolates of Aureobasidium pullulans var. pullulans and A. pullulans var. melanigenum revealed low MIC90s of amphotericin B, posaconazole, and itraconazole. However, they were resistant to fluconazole (≥64 μg/ml) and had high MICs of voriconazole, isavuconazole, caspofungin, and micafungin.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25001309      PMCID： PMC4135826          DOI： 10.1128/AAC.03095-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  Disseminated nosocomial fungal infection by Aureobasidium pullulans var. melanigenum: a case report.

Authors:  Giuseppe Bolignano; Giuseppe Criseo
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

2.  Chronic fungal meningitis caused by Aureobasidium proteae.

Authors:  Marko Kutleša; Emilija Mlinarić-Missoni; Lóránt Hatvani; Darko Voncina; Silvio Simon; Dragan Lepur; Bruno Baršić
Journal:  Diagn Microbiol Infect Dis       Date:  2012-04-14       Impact factor: 2.803

3.  A multigene phylogeny of the Dothideomycetes using four nuclear loci.

Authors:  Conrad L Schoch; Robert A Shoemaker; Keith A Seifert; Sarah Hambleton; Joseph W Spatafora; Pedro W Crous
Journal:  Mycologia       Date:  2006 Nov-Dec       Impact factor: 2.696

4.  Subcutaneous mycosis and fungemia by Aureobasidium pullulans: a rare pathogenic fungus in a post allogeneic BM transplant patient.

Authors:  A Joshi; R Singh; M S Shah; S Umesh; N Khattry
Journal:  Bone Marrow Transplant       Date:  2009-06-01       Impact factor: 5.483

5.  Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?

Authors:  A Espinel-Ingroff; M C Arendrup; M A Pfaller; L X Bonfietti; B Bustamante; E Canton; E Chryssanthou; M Cuenca-Estrella; E Dannaoui; A Fothergill; J Fuller; P Gaustad; G M Gonzalez; J Guarro; C Lass-Flörl; S R Lockhart; J F Meis; C B Moore; L Ostrosky-Zeichner; T Pelaez; S R B S Pukinskas; G St-Germain; M W Szeszs; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2013-09-09       Impact factor: 5.191

Review 6.  Catheter-related septicemia due to Aureobasidium pullulans.

Authors:  Yu-Tsung Huang; Shwu-Jen Liaw; Chun-Hsing Liao; Jia-Ling Yang; Dar-Ming Lai; Yung-Chie Lee; Po-Ren Hsueh
Journal:  Int J Infect Dis       Date:  2008-05-02       Impact factor: 3.623

Review 7.  Aureobasidium pullulans infection: fungemia in an infant and a review of human cases.

Authors:  Michael Hawkes; Robert Rennie; Crystal Sand; Wendy Vaudry
Journal:  Diagn Microbiol Infect Dis       Date:  2005-03       Impact factor: 2.803

8.  Aureobasidium mansoni meningitis in a leukemia patient successfully treated with amphotericin B.

Authors:  V Krcméry; S Spánik; A Danisovicová; Z Jesenská; M Blahová
Journal:  Chemotherapy       Date:  1994 Jan-Feb       Impact factor: 2.544

9.  ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi.

Authors:  A Chowdhary; J F Meis; J Guarro; G S de Hoog; S Kathuria; M C Arendrup; S Arikan-Akdagli; M Akova; T Boekhout; M Caira; J Guinea; A Chakrabarti; E Dannaoui; A van Diepeningen; T Freiberger; A H Groll; W W Hope; E Johnson; M Lackner; K Lagrou; F Lanternier; C Lass-Flörl; O Lortholary; J Meletiadis; P Muñoz; L Pagano; G Petrikkos; M D Richardson; E Roilides; A Skiada; A M Tortorano; A J Ullmann; P E Verweij; O A Cornely; M Cuenca-Estrella
Journal:  Clin Microbiol Infect       Date:  2014-04       Impact factor: 8.067

10.  Redefinition of Aureobasidium pullulans and its varieties.

Authors:  P Zalar; C Gostincar; G S de Hoog; V Ursic; M Sudhadham; N Gunde-Cimerman
Journal:  Stud Mycol       Date:  2008       Impact factor: 16.097
View more
  9 in total

1.  In Vitro Antifungal Activities against Moulds Isolated from Dermatological Specimens.

Authors:  Tzar Mohd Nizam; Rabiatul Adawiyah Ag Binting; Shafika Mohd Saari; Thivyananthini Vijaya Kumar; Marianayati Muhammad; Hartini Satim; Hamidah Yusoff; Jacinta Santhanam
Journal:  Malays J Med Sci       Date:  2016-05

Review 2.  Black Molds and Melanized Yeasts Pathogenic to Humans.

Authors:  Anuradha Chowdhary; John Perfect; G Sybren de Hoog
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

3.  Fungemia due to Aureobasidium pullulans.

Authors:  Jorge Verdecia; Christopher A Jankowski; Meredith L Reynolds; Yvette McCarter; Malleswari Ravi
Journal:  Med Mycol Case Rep       Date:  2022-07-05

Review 4.  Superficial Phaeohyphomycosis Caused by Aureobasidium melanogenum Mimicking Tinea Nigra in an Immunocompetent Patient and Review of Published Reports.

Authors:  Wan-Ting Chen; Mei-Eng Tu; Pei-Lun Sun
Journal:  Mycopathologia       Date:  2016-02-16       Impact factor: 2.574

5.  Successful treatment of Aureobasidium pullulans central catheter-related fungemia and septic pulmonary emboli.

Authors:  Sanjay R Mehta; Scott Johns; Paul Stark; Joshua Fierer
Journal:  IDCases       Date:  2017-09-14

6.  Unconventional Yeasts Are Tolerant to Common Antifungals, and Aureobasidium pullulans Has Low Baseline Sensitivity to Captan, Cyprodinil, and Difenoconazole.

Authors:  Electine Magoye; Maja Hilber-Bodmer; Melanie Pfister; Florian M Freimoser
Journal:  Antibiotics (Basel)       Date:  2020-09-15

7.  Aureobasidium melanigenum catheter-related bloodstream infection: a case report.

Authors:  Shinya Yamamoto; Mahoko Ikeda; Yuki Ohama; Tomohiro Sunouchi; Yasutaka Hoshino; Hiroshi Ito; Marie Yamashita; Yoshiaki Kanno; Koh Okamoto; Satoshi Yamagoe; Yoshitsugu Miyazaki; Shu Okugawa; Jun Fujishiro; Kyoji Moriya
Journal:  BMC Infect Dis       Date:  2022-04-05       Impact factor: 3.090

8.  Fungemia caused by Aureobasidium pullulans in a patient with advanced AIDS: a case report and review of the medical literature.

Authors:  Jaimie Mittal; Wendy A Szymczak; Liise-Anne Pirofski; Benjamin T Galen
Journal:  JMM Case Rep       Date:  2018-03-14

9.  Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures.

Authors:  Youcef Megri; Amir Arastehfar; Teun Boekhout; Farnaz Daneshnia; Caroline Hörtnagl; Bettina Sartori; Ahmed Hafez; Weihua Pan; Cornelia Lass-Flörl; Boussad Hamrioui
Journal:  Antimicrob Resist Infect Control       Date:  2020-04-07       Impact factor: 4.887
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.